latest news in companies

Linas Agro Secures 30 Million Euros from Citibank to Power Grain Exports

Linas Agro Secures 30 Million Euros from Citibank to Power Grain Exports

Panevėžys, Monday, 12 January 2026.
In a significant move for Lithuanian agribusiness, Linas Agro secured 30 million euros from Citibank to finance grain operations at the Port of Klaipeda and strengthen global export chains.

HyProMag USA Targets Tripled Domestic Magnet Output with $2 Billion Expansion Plan

HyProMag USA Targets Tripled Domestic Magnet Output with $2 Billion Expansion Plan

New York, Monday, 12 January 2026.
HyProMag USA completes studies to triple domestic rare earth magnet production by 2029, unlocking a projected $2 billion valuation while securing a critical U.S. supply chain.

Gausium Launches Adaptive Robotic Cleaning Fleet at NRF 2026

Gausium Launches Adaptive Robotic Cleaning Fleet at NRF 2026

New York, Monday, 12 January 2026.
At NRF 2026 today, Gausium unveiled a versatile robotic lineup, notably the PhanShop, which simultaneously cleans floors and displays advertisements, maximizing utility for modern retail environments.

Exosens Secures Largest Ever Contract for Next-Generation Night Vision Technology

Exosens Secures Largest Ever Contract for Next-Generation Night Vision Technology

Merignac, Monday, 12 January 2026.
Supplying over 7,000 units, this deal equips European Special Forces with technology boosting detection ranges by 35 percent, marking a pivotal advancement in defense capabilities.

Fagron Bolsters North American Presence with $41.5 Million Strategic Acquisition

Fagron Bolsters North American Presence with $41.5 Million Strategic Acquisition

Rotterdam, Monday, 12 January 2026.
Fagron cements its North American expansion by finalizing the $41.5 million acquisition of University Compounding Pharmacy, immediately adding $25 million in annual revenue to its personalized medicine portfolio.

Sanofi Wins First EU Approval for Therapy Delaying Type 1 Diabetes Onset

Sanofi Wins First EU Approval for Therapy Delaying Type 1 Diabetes Onset

Paris, Monday, 12 January 2026.
On January 12, 2026, Sanofi achieved a significant regulatory milestone as the European Commission approved Teizeild (teplizumab), marking the European Union’s first disease-modifying therapy authorized to delay the onset of stage 3 type 1 diabetes. This approval, applicable to adults and children aged eight and older with stage 2 diabetes, is grounded in compelling data from the TN-10 Phase 2 study. The trial demonstrated that Teizeild could delay disease progression by a median of two years, a critical timeframe for patients and families. Analytically, the results were robust: 57% of patients treated with the therapy remained in stage 2, compared to only 28% in the placebo group. This authorization not only strengthens Sanofi’s immunology portfolio but represents a paradigm shift in diabetes management, moving from reactive symptomatic treatment to proactive preventative intervention for high-risk individuals across the European market.

Tow.Market Launches AI Marketplace to Modernize Roadside Assistance

Tow.Market Launches AI Marketplace to Modernize Roadside Assistance

New York, Monday, 12 January 2026.
Valued at $15 million, Tow.Market officially launched its “Uber-like” AI platform today, aiming to digitize the fragmented towing industry through real-time dispatch and transparent pricing.

Trump Signals Intent to Exclude ExxonMobil from Venezuela Following CEO's Skepticism

Trump Signals Intent to Exclude ExxonMobil from Venezuela Following CEO's Skepticism

Washington D.C., Monday, 12 January 2026.
Labeling ExxonMobil’s caution as “playing too cute,” President Trump signaled plans to bar the energy giant from Venezuela after CEO Darren Woods deemed the current legal framework “uninvestable.”

Avatar: Fire and Ash Retains Top Box Office Spot for Fourth Consecutive Weekend

Avatar: Fire and Ash Retains Top Box Office Spot for Fourth Consecutive Weekend

Los Angeles, Monday, 12 January 2026.
James Cameron’s sequel generated $21.3 million domestically, becoming the first film since Barbie to lead for four straight weekends, driving global earnings past $1.23 billion.

Faraday Future Confirms February Robotics Launch in 2026 Strategic Outlook

Faraday Future Confirms February Robotics Launch in 2026 Strategic Outlook

Los Angeles, Monday, 12 January 2026.
On February 4, Faraday Future expands beyond electric vehicles, launching its first AI robotics products at the NADA Show to drive its ambitious dual-growth strategy for 2026.